Gene therapy helps dogs with muscle dystrophy, humans next?

(iStock)
(iStock)

Paris - Researchers have used gene editing to reverse symptoms in dogs of Duchenne muscular dystrophy (DMD) - a muscle-wasting and life-shortening disease that affects one in 5 000 baby boys.

The dogs' symptoms remained in check two years after receiving a single injection, a team reported on Tuesday in the journal Nature Communications.

Successful treatment of a large mammal is a crucial step on the road to finding a treatment for human sufferers of DMD.

The results, said the team, were "paving the way for human clinical trials".

Duchenne muscular dystrophy is caused by genetic mutations that interfere with production of dystrophin, a protein needed for healthy muscles.

The international team developed a new type of gene transfer therapy to restore dystrophin expression in affected dogs.

They injected the dogs with "microdystrophin" - a compressed version of the dystrophin gene which is one of the largest in the human body with 2.3 million base pairs of coding "letters".

Given its size, it has been impossible to fit the distrophin gene into an emptied virus, which is used to deliver modified genes to patients.

Dogs given the treatment showed "significant restoration of muscle function with a stabilisation of clinical symptoms for more than two years after injection", the researchers said in a statement.

Geneticist Darren Griffin of the University of Kent commented that this was "really a very exciting study indeed".

"The disease has long been a target for gene therapy and it is only to be hoped that sufficient funds can be awarded for this research to reach its natural conclusion and go into full clinical trials," he said via the Science Media Centre.

Boys affected by Duchenne muscular dystrophy develop muscle weakness in their first year of life, and generally become wheelchair-bound before the age of 15.

Muscle wasting and breathing and heart problems follow, and patients rarely survive into their 40s.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Who do you think is going to win the 2020 US election?
Please select an option Oops! Something went wrong, please try again later.
Results
Biden is going to take it
46% - 5412 votes
It's four more years for Trump
54% - 6430 votes
Vote
ZAR/USD
16.46
(+0.21)
ZAR/GBP
21.33
(+0.24)
ZAR/EUR
19.48
(-0.22)
ZAR/AUD
11.61
(+0.34)
ZAR/JPY
0.16
(+0.28)
Gold
1907.17
(+0.24)
Silver
24.62
(+5.30)
Platinum
872.00
(+2.22)
Brent Crude
42.85
(-0.67)
Palladium
2405.00
(+3.19)
All Share
55271.75
(+0.20)
Top 40
50851.62
(+0.22)
Financial 15
9956.35
(-0.22)
Industrial 25
75567.07
(+1.08)
Resource 10
53788.16
(-0.63)
All JSE data delayed by at least 15 minutes morningstar logo